Because its trial designs do not meet even the basic minimum criteria set forth by the Food and Drug Administration (FDA) for new vaccines, AstraZeneca’s adenovirus-vector vaccine for the Wuhan coronavirus (COVID-19) will “never be licensed in the U.S.,” says SVB Leerink health-care analyst George Porges. Despite claims that the jab is 70 percent effective – … Continue reading AstraZeneca’s COVID-19 vaccine will “never be licensed in the US,” says analyst
Dr. Eddy Bettermann MD 